Ranked by market cap
| # | Company | Ticker | Sector | Market Cap | Screening basis |
|---|---|---|---|---|---|
| 1 | SAMSUNG BIOLOGICS | 207940.KS | Healthcare | $62.3T | Research-based |
| 2 | Celltrion | 068270.KS | Healthcare | $39.8T | Research-based |
| 3 | HOYA CORP | 7741.T | Healthcare | $8.9T | Research-based |
| 4 | Eli Lilly CDR (CAD Hedged) | LLY | Healthcare | $897.7B | Research-based |
| 5 | Johnson & Johnson CDR (CAD Hedged) | JNJ | Healthcare | $555.6B | Research-based |
| 6 | Roche CDR (CAD Hedged) | ROG | Healthcare | $330.4B | Research-based |
| 7 | AstraZeneca PLC Ordinary Shares | AZN | Healthcare | $286.8B | Research-based |
| 8 | Novartis CDR (CAD Hedged) | NVS | Healthcare | $285.8B | Research-based |
| 9 | Merck CDR (CAD Hedged) | MRK | Healthcare | $280.1B | Research-based |
| 10 | ROCHE I | RO.SW | Healthcare | $269.2B | Research-based |
| 11 | ROCHE PS | ROP.SW | Healthcare | $262.2B | Research-based |
| 12 | NOVARTIS N | NOVN.SW | Healthcare | $227.1B | Research-based |
| 13 | Intuit CDR (CAD Hedged) | INTU | Healthcare | $151.6B | Research-based |
| 14 | Intuitive Surgical CDR (CAD Hedged) | ISRG | Healthcare | $151.6B | Research-based |
| 15 | Stryker CDR (CAD Hedged) | SYK | Healthcare | $117.1B | Research-based |
| 16 | Vertex Pharmaceuticals Incorporated - Common Stock | VRTX | Healthcare | $109.2B | Research-based |
| 17 | Sanofi CDR (CAD Hedged) | SNY | Healthcare | $102.7B | Research-based |
| 18 | Medtronic plc. Ordinary Shares | MDT | Healthcare | $98.8B | Research-based |
| 19 | McKesson Corporation Common Stock | MCK | Healthcare | $89.8B | Research-based |
| 20 | Regeneron Pharmaceuticals, Inc. - Common Stock | REGN | Healthcare | $68.1B | Research-based |
| 21 | argenx SE - American Depositary Shares | ARGX | Healthcare | $50.3B | Research-based |
| 22 | CSL FPO [CSL] | CSL.AX | Healthcare | $47.2B | Research-based |
| 23 | Edwards Lifesciences Corporation Common Stock | EW | Healthcare | $46.8B | Research-based |
| 24 | IDEXX Laboratories, Inc. - Common Stock | IDXX | Healthcare | $43.7B | Research-based |
| 25 | RESMED CDI 10:1 [RMD] | RMD.AX | Healthcare | $42.4B | Research-based |